Current Advances in Immunoassays for the Detection of β2-Agonists
- PMID: 35327226
- PMCID: PMC8947354
- DOI: 10.3390/foods11060803
Current Advances in Immunoassays for the Detection of β2-Agonists
Abstract
β2-agonists are a group of synthetic phenylethanolamine compounds which are traditionally used for treating bronchospasm. These compounds can also increase skeletal muscle mass and decrease body fat. The illegal use of β2-agonists in food-producing animals results in residue of β2-agonists in edible tissues and causes adverse health effects in humans. Thus, the detection of β2-agonists at trace level in complex sample matrices is of great importance for monitoring the abuse of β2-agonists. Many methods have been developed to detect β2-agonists. Among them, a variety of antigen-antibody interaction-based techniques have been established to detect β2-agonists in various samples, including animal feed, urine, serum, milk, tissues and hair. In this review, we summarized current achievement in the extraction of β2-agonists from testing samples and detection of β2-agonists using immunological techniques. Future perspectives were briefly discussed.
Keywords: ELISA; chemiluminescent immunoassay; food safety; immunoassay; immunosensor; lateral flow immunoassay; radioimmunoassay; sample extraction; β2-agonist.
Conflict of interest statement
The authors declare no conflict of interest.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources